In vitro activity of ciprofloxacin, azthreonam and ceftazidime againstSerratia marcescens andPseudomonas aeruginosa
- 1 August 1984
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 3 (4) , 368-369
- https://doi.org/10.1007/bf01977498
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1983
- Norfloxacin (MK-0366, AM-715): In vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testingDiagnostic Microbiology and Infectious Disease, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of azthreonam, a monobactam antibioticAntimicrobial Agents and Chemotherapy, 1982
- Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.Journal of Antimicrobial Chemotherapy, 1981
- Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compoundsAntimicrobial Agents and Chemotherapy, 1980